Executive Summary
These 21 new federal contracts, aggregated at $1,703,423,541 total obligation over April 8, 2026, are entirely civilian with 0/21 defense-related, emphasizing HHS/BARDA biotech R&D, GSA/VA/State/Treasury IT services, and facilities support. Dominant agency themes include HHS ($198M+ across Shionogi and Vedanta), Treasury/IRS ($200M+ via two IBM awards), and VA ($219M+ via Salient CRGT, General Dynamics IT, Greenbrier). Highest-conviction bullish signal is Shionogi Inc's $119M HHS BARDA cost-plus-fixed-fee contract for biothreat antibiotics, with $481M potential over 10 years. Balanced by neutral/dated awards like Smartronix $116M GSA IT (2018-2023, negative outlays) and IBM $110M Treasury terminated in 2025. Key risk/watch: $0 outlays on 8 contracts (e.g., Shionogi, ManTech $77M), signaling near-term execution uncertainty amid CR risk for FY2026 awards.
Tracking the trend? Catch up on the prior New Federal Contractors digest from April 07, 2026.
Investment Signals(7)
- Shionogi Inc Secures $119M HHS BARDA Biotech R&D Contract(HIGH)▲
Shionogi Inc awarded $119,160,691 cost-plus-fixed-fee contract by HHS BARDA for antibiotics targeting drug-resistant infections and biothreats, with base + options at $481M over 10 years to 2036-03-10; $0 outlayed but low pricing risk supports multi-year revenue.
- Salient CRGT Wins $93M VA IT Delivery Order(HIGH)▲
Salient CRGT Inc received $93,004,285 time-and-materials delivery order from VA Technology Acquisition Center for technical application platforms (NAICS 541512), with $198M potential over 2-5 years to 2030-04-10 and $21.8M already outlayed.
- ManTech $77M GSA USSOUTHCOM Cyber IT Award with $909M Ceiling(MEDIUM)▲
ManTech Advanced Systems International (parent ManTech International) awarded $77,416,388 cost-plus-award-fee GSA delivery order for USSOUTHCOM Cyber IT Enterprise Services 2, with $909M base + options potential to 2032-08-07 despite $0 outlayed.
- Vedanta Biosciences $79M HHS BARDA Antibiotic Countermeasures(HIGH)▲
Vedanta Biosciences Inc (small business) secured $79,146,088 cost-sharing contract from HHS BARDA for biotech R&D against antibiotic-resistant infections, with $70.7M outlayed and potential to $114M through 2031-12-31.
- IBM $110M Treasury Contract Terminated for Convenience(HIGH)▲
IBM's $110,364,715 firm-fixed-price IRS e-file modernization delivery order fully outlayed but terminated 2025-03-24 per executive orders, limiting future revenue despite $70M subawards.
- IBM $90M IRS Modernized E-File Continuation(MEDIUM)▲
IBM awarded follow-on $90,374,191 firm-fixed-price delivery order from IRS IT Operations for MEF services (NAICS 541512), with $147M potential to 2029-03-29 and $50.5M outlayed.
- GEO Group $67M ICE Detention Services Order(MEDIUM)▲
The GEO Group Inc awarded $66,893,395 firm-fixed-price delivery order by ICE for Aurora CO detention facility services (NAICS 561210), ~$80M annualized over 10 months to 2026-08-15.
Risk Flags(4)
- Execution[HIGH RISK]▼
8 contracts with $0 outlays including Shionogi $119M HHS, ManTech $77M GSA, Deloitte $70M State, signaling delayed spending amid FY2026 CR uncertainty.
- Budget[MEDIUM RISK]▼
IBM $110M Treasury contract terminated 2025-03-24 for convenience per executive orders, with full $110M outlayed but no future revenue.
- Execution[HIGH RISK]▼
High fixed-price risk on Quality Support $113M State SDVOSB set-aside and Life Science Logistics $73M GSA pharma storage, both with $0 or partial outlays over long periods to 2026.
- Concentration[MEDIUM RISK]▼
General Dynamics IT $65M VA delivery order with $61M subawards (93% passthrough), materially reducing net prime revenue.
Opportunities(4)
- ◆
Shionogi $119M and Vedanta $79M HHS BARDA biotech R&D contracts for biothreat/antibiotic countermeasures, with $481M/$114M potentials over 10+ years.
- ◆
ManTech $77M GSA USSOUTHCOM cyber IT with $909M ceiling to 2032, Salient CRGT $93M VA IT to $198M.
- ◆
IBM dual IRS awards totaling $200M ($110M terminated + $90M active to $148M), signaling Treasury IT modernization continuity.
- ◆
Greenbrier Government Solutions $61M VA SDVOSB set-aside for CA Technologies software, $54M outlayed to 2026.
Sector Themes(3)
- ◆
Shionogi $119M and Vedanta $79M cost-plus contracts for antibiotics R&D against drug-resistant/biothreat pathogens (NAICS 541714), with $70M+ outlays on Vedanta and long 10-year potentials.
- ◆
9 contracts totaling ~$700M+ including Salient CRGT $93M VA, IBM $90M IRS, ManTech $77M GSA cyber, Deloitte $70M State, mostly full/open competition with multi-year options.
- ◆
Syncom $100M NASA facilities (98% outlayed), ENSCO $70M DOT rail inspection to 2027, signaling steady R&D/ops demand.
Watch List(5)
- 👁
{"entity"=>"Shionogi Inc", "reason"=>"$119M HHS BARDA contract with $0 outlayed and $481M options over 10 years", "trigger"=>"outlay progress, FDA milestones"}
- 👁
{"entity"=>"ManTech International (MANT)", "reason"=>"$77M GSA USSOUTHCOM cyber IT with $909M ceiling, $0 outlayed, 43 subawards $161M", "trigger"=>"option exercises beyond 2026-04-24"}
- 👁
{"entity"=>"IBM (IBM)", "reason"=>"$90M active IRS MEF vs prior $110M terminated; $50M outlayed on active", "trigger"=>"option exercises to $148M, re-compete announcements"}
- 👁
{"entity"=>"Salient CRGT Inc", "reason"=>"$93M VA IT with $21.8M outlayed toward $198M potential to 2030", "trigger"=>"outlay updates, option exercises"}
- 👁
{"entity"=>"The GEO Group (GEO)", "reason"=>"$67M ICE detention order ~$80M annualized over 10 months, $0 outlayed", "trigger"=>"outlay start post-2025-10-16, 2026-08-15 end"}
Get daily alerts with 7 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 21 filings
More from: New Federal Contractors
🇺🇸 More from United States
View all →April 22, 2026
US Pre-Market SEC Filings Roundup — April 22, 2026
US Pre-Market SEC Filings Roundup
April 22, 2026
Contract Option Exercises — April 22, 2026
Contract Option Exercises
April 22, 2026
Contract Deobligations Alert — April 22, 2026
Contract Deobligations Alert
April 22, 2026
Significant Contract Modifications ($10M+) — April 22, 2026
Significant Contract Modifications ($10M+)